Sugar Amino Acids: Synthesis
and NMR-Structural Analysis of Linear and Cyclic Homooligomers
Sibylle Gruner, Elsa Locardi, Matthias Stöckle, Horst Kessler
Institut für Organische Chemie und Biochemie, Technische Universität
München, Lichtenbergstr. 4, 85747 Garching, Germany
Sugar Amino Acids (SAAs) are sugar moieties containing at least one
amino as well as at least one carboxyl group. In this work we studied them
mainly as structural templates in respect to their ability to induce new,
potentially useful structures for peptidomimetic drug design. They can
be used as substitutes for conventional amino acids or peptide fragments
[1]. Sugar amino acid monomeres 1, 2 were synthesised starting
from diacetoneglucose. The amino group was introduced via activation of
the hydroxyl group with triflate anhydride, azidolysis (70%), and reduction.
Using standard solid phase coupling procedures 1 and 2 were alternatively
coupled with b-alanine or GABA to form trimers up to hexamers (3,
4).
The solution structure in DMSO and pyridine were investigated by 2-D NMR
techniques as well as by CD-spectroscopy.
[1] E. Lohof, F. Burkhart, M. A. Born, E. Planker, H. Kessler, Advances
in Amino Acid Mimetics and Peptidomimetics, Vol. 2 (Ed: Abell, A.) JAI
Press Inc., Stanford, Connecticut, pp. 263-292.
|
Linear and Cyclic Oligomers of Two New Furanoid Sugar
Amino Acids
Sibylle Gruner, Horst Kessler
Institut für Organische Chemie und Biochemie, Technische
Universität München, Lichtenbergstr. 4, 85747 Garching, Germany
Introduction
Sugar Amino Acids (SAAs) are sugar moieties
containing at least one amino as well as at least one carboxyl group. In
this work the new SAAs 1 and 2 as well as their mixed linear
and cyclic hexapeptides 3, 4, and 5 are described
(Scheme 1). We studied them mainly as structural templates in respect
to their ability to induce new, potentially useful structures for peptidomimetic
drug design. SAAs can be used as substitutes for conventional amino acids
or peptide fragments [1]. b- and g-peptides
as well as SAA-oligomers have been shown to form stable secondary structures
in solution [2-5].
Scheme 1: b- and g-SAA
1
and 2, their mixed linear oligomers 3 and 4 as well
as cyclic oligomer 5.
Results and Discussion
The synthesis of SAAs 1 and 2 is shown in Scheme 2.
Both were synthesized via the azides 6 and 7. The crucial
step is the azidolysis of the triflate activated diacetoneglucose. Considerable
higher yields than given in ref. [6-8] were obtained, by using the cheaper
and less hazardous reagents NaN3 and catalytic amounts of Bu4NCl.
After 3-5 h the azide 6 was obtained by reaction of the triflate
activated diacetoneglucose with 2 eq. NaN3 in DMF at 50 °C,
using catalytic amounts of Bu4NCl, thus suppressing elimination
more sufficiently. Azidolysis is followed by quantitative deprotection
of the exocyclic hydroxyl groups using acetic acid [9]. In a one-pot reaction
the azide was reduced and simultaneously Fmoc-protected yielding about
70 % of the Fmoc-protected amine.
Scheme 2: Synthesis of SAAs 1 and 2.
To prevent decarboxylation during TEMPO oxidation, it is crucial to
avoid too basic conditions, and to keep the temperature below 0 °C.
Using TCP resin and HATU/collidine as coupling reagents 1
and 2 were alternatively coupled with b-alanine or GABA respectively
to form hexapeptides 3 and 4. After deprotection 3
was cyclisized using HATU/collidine to afford 5 in quantitative
yield.
2D NMR showed 5 to be C3 symmetric on the NMR
timescale, while for the linear hexapeptides 3 and 4 each
residue shows its own, complete, distinguishable set of chemical shifts.
Figure 1: TOCSY of the amide region of the mixed oligomers 3
and 5.
At present it remains uncertain, whether a single structure or a structural
ensemble fit the observed NOE data sets.
References
1. Lohof, E., Burkhart, F., Born, M. A., Planker, E., Kessler, H. In
Abell, A. (Ed.), Advances in Amino Acid Mimetics and Peptidomimetics, JAI
Press Inc.: Stanford, Connecticut, USA, 1999, Vol. 2, p 263.
2. Seebach, D., Overhand, M., Kühnle, F. N. M., Martinoni, B.,
Oberer, L., Hommel, U., Widmer, H. Helv. Chim. Acta 79, (1996), 913.
3. Appella, D. H., Christianson, L. A., Karle, I. L., Powell, D. R.,
Gellman, S. H. J. Am.Chem. Soc., 118, (1996), 13071.
4. Appella, D. H., Christianson, L. A., Klein, D. A., Powell, D. R.,
Huang, X., Barchi Jr, J. J., Gellman, S. H. Nature, 38, (1997), 381.
5. Long, D. D., Smith, M. D., Marquess, D., Claridge, T. D. W., Fleet,
G. W. J. Tetrahedorn Lett., 39, (1998), 9293.
6. Daley, L., Monneret, C., Gautier, C., Roger, P. Tetrahedron Lett.,
33, (1992), 3749.
7. Fernández, J. M. G., Mellet, C. O., Blanco, J. L. J., Fuentes,
J. J. Org. Chem., 59, (1994), 5565.
8. Baer, H. H., Gan, Y. Carbohydrate Research, 210, (1991), 233.
9. Kulinkovich, L. N., Timoshchuk, V. A. J. Gen. Chem. USSR (Engl.
Transl.), 53, (1983), 1917.
|
Active Somatostatin Analogues Containing Sugar Amino
Acids
Sibylle Gruner,1 Horst Kessler,1 Gyorgy Kéri,2
and Aniko Venetianer3
1 Novaspin Biotech GmbH, 85748 Garching, Germany;
2 Department of Medicinal Chemistry, Semmelweis Medicinal University, H-1444.
Budapest 8; and 3 Inst. of Genetics, Biological Research Center, Hungarian
Academy of Sciences, 6726 Szeged Temesvari krt. 62, Hungary
Introduction
Sugar Amino Acids (SAAs) are sugar moieties containing at least one
amino as well as at least one carboxyl group[1]. Their oligomers represent
chimeras between the two big classes of biopolymers, the carbohydrates
and proteins. They therefore have been used as both, carbohydrate and peptidomimetics
[2]. SAAs have been used in our laboratory mainly as turnmimics. We also
applied SAAs to improve bioavailability and selectivity by functionalizing
the carbohydrate skeleton.
Results and Discussion
In this work we present the development of new, SAA?containing somatostatin
analogues.[3] A library of compounds containing different furanoid and
pyranoid SAAs have been synthesized (Fig. 1). Hereby the skeleton and the
functional groups of the SAAs as well as the amino acids of the peptide
backbone have been optimized.
Fig. 1. SAA containing somatostatin analogous. R, R’,R’’ = H, Bn,
or ketal groups
Some SAA containing somatostatin analogues induce apoptosis most effectively.
Remarkably analogues containing D- and L-tryptophane are both active.
The simple and straight forward synthesis of SAAs 1 and 2, which serve
as structure inducing templates in our compounds, is shown in Scheme 1.
Both were synthesized via the azides 6 and 7. The crucial step is the azidolysis
of the triflate activated diacetoneglucose. Considerable higher yields
than given in ref. [4-6] were obtained, by using the cheaper and less hazardous
reagents NaN3 and catalytic amounts of Bu4NCl. Azidolysis is followed by
quantitative deprotection of the exocyclic hydroxyl groups using acetic
acid [7]. In a one-pot reaction the azide was reduced and simultaneously
Fmoc-protected yielding about 70 % of the Fmoc-protected amine.
Scheme 1: Synthesis of structure inducing furanoid SAAs 1 and 2.
To prevent decarboxylation during TEMPO oxidation, it is crucial to
avoid too basic conditions, and to keep the temperature below 0 °C.
References
1. Lohof, E., Burkhart, F., Born, M. A., Planker, E., Kessler, H., Advances
in Amino Acid Mimetics and Peptidomimetics, Vol. 2 (Ed.: Abell, A), JAI
Press Inc., Stanford, Connecticut, 1999, p. 263.
2. Gruner, S., Locardi, E., Lohof, E., Kessler, H., Chem. Rev., april,
(2002).
3. Gruner, S., Locardi, E., Lohof, E., Born, M., Mang, C., Kéri,
G., Venetianer, A., Kessler, H., J. Med. Chem., in preparation.
4. Daley, L., Monneret, C., Gautier, C., Roger, P., Tetrahedron Lett.,
33, 3749, (1992).
5. Fernández, J. M. G., Mellet, C. O., Blanco, J. L. J., Fuentes,
J., J. Org. Chem., 59, 5565, (1994).
6. Baer, H. H., Gan, Y., Carbohydr. Res., 210, 233, (1991).
7. Kulinkovich, L. N., Timoshchuk, V. A., J. Gen. Chem. USSR (Engl.
Transl.), 53, 1917, (1983).
|